...
首页> 外文期刊>Foot & Ankle Orthopaedics >Impact of Vancomycin Treatment on Human Mesenchymal Stromal Cells During Osteogenic Differentiation:
【24h】

Impact of Vancomycin Treatment on Human Mesenchymal Stromal Cells During Osteogenic Differentiation:

机译:万古霉素治疗对成骨细胞分化过程中人间质基质细胞的影响:

获取原文
           

摘要

Category:Basic Sciences/BiologicsIntroduction/Purpose:Vancomycin is often delivered locally for surgical site infection prophylaxis. Recent reports of possible osteotoxicity have led to uncertainty concerning vancomycin’s safety in the setting of arthrodesis and bone healing. Bone formation during arthrodesis takes place as recruited human mesenchymal stromal cells (hMSCs) proliferate and differentiate into mature osteoblasts. The purpose of this research was to determine the impact of vancomycin treatment on hMSCs during osteogenic differentiation.Methods:Human MSCs were cultured in MSC growth media to an appropriate confluence. Cells were cultured for 24 hours to facilitate adherence, after which the media was aspirated and replaced with osteogenic differentiation media (Lonza, Switzerland). Osteogenic differentiation media was supplemented with vancomycin powder to yield solutions with concentrations of 0, 50, 500 & 5000 μg/mL. Fresh vancomycin powder was added with every media change. MSCs viability a...
机译:类别:基础科学/生物制剂简介/目的:通常将万古霉素局部递送以预防手术部位感染。有关可能的骨毒性的最新报道导致万古霉素在关节固定和骨愈合方面的安全性尚不确定。当募集的人间充质基质细胞(hMSCs)增殖并分化为成熟的成骨细胞时,就会发生关节形成过程中的骨形成。本研究的目的是确定万古霉素治疗对成骨分化过程中hMSC的影响。方法:将人MSC在MSC生长培养基中培养至合适的汇合度。培养细胞24小时以促进粘附,之后吸出培养基并用成骨分化培养基(Lonza,瑞士)代替。成骨分化培养基中补充了万古霉素粉末,以产生浓度为0、50、500和5000μg/ mL的溶液。每次更换培养基时都加入新鲜的万古霉素粉末。 MSC的生存能力

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号